Seeing Is Believing

Currently out of the existing stock ratings of Maneka Mirchandaney, 10 are a BUY (66.67%), 5 are a HOLD (33.33%).
Analyst Maneka Mirchandaney, carries an average stock price target met ratio of 63.33% that have a potential upside of 45.43% achieved within 324 days. Previously, Maneka Mirchandaney worked at EVERCORE.
Maneka Mirchandaney’s has documented 31 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 15-May-2026.
Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 5/17/2021. The price target of $153 was fulfilled within 3 days with a profit of $5.02 (3.39%) receiving and performance score of 11.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Sep-2026
1 months 20 days ago
(02-Sep-2026)
5/8 (62.5%)
$48.39 (116.29%)
407
Buy Since 02-Jul-2026
$85
$0.05 (0.06%)
$55
2 months 24 days ago
(28-Jul-2026)
1/2 (50%)
$1.14 (1.36%)
5
Buy Since 05-Jan-2026
$85
$0.05 (0.06%)
$90
3 months 14 days ago
(08-Jul-2026)
0/2 (0%)
$1.51 (1.81%)
Buy Since 13-Aug-2018
3 months 14 days ago
(08-Jul-2026)
5/5 (100%)
$26.41 (194.33%)
1556
Buy Since 07-Jul-2026
$85
$0.05 (0.06%)
$55
3 months 15 days ago
(07-Jul-2026)
1/2 (50%)
$1.47 (1.76%)
356
Which stock is Maneka Mirchandaney most bullish on?
Which stock is Maneka Mirchandaney most reserved on?